SCPH Stock Risk & Deep Value Analysis

scPharmaceuticals Inc.

Healthcare • Biotechnology

DVR Score

8.4

out of 10

Hidden Gem

The Bottom Line on SCPH

We analyzed scPharmaceuticals Inc. using our deep value framework. Sign in to see our full verdict and DVR Score.

We ran SCPH through our deep value framework — analyzing financial health, distress signals, competitive moat, and risk factors. Here's what we found.

Updated Oct 7, 2025•Run Fresh Analysis →

📈SCPH Performance Overview3yr weekly

📊

Unlock SCPH Performance Chart

See 3 years of price history, quarterly revenue trends, and DVR score changes

Weekly adjusted close · Quarterly revenue & EPS · DVR score history

About scPharmaceuticals Inc. (SCPH)

Sector

Healthcare

Industry

Biotechnology

Market Cap Category

small

Market Cap

$304.36M

SCPH Deep Value Analysis

SCPH exhibits strong 10x potential through Furoscix, a first-in-class, FDA-approved at-home heart failure treatment addressing a significant market and reducing hospitalizations. Its proprietary technology creates a clear competitive moat. Catalysts include rapid commercial ramp-up and expanding payer access. While leadership has executed on approvals, the key risk is commercial execution, requiring substantial revenue growth to justify current burn and avoid significant future dilution. Strong institutional sentiment exists, validating the opportunity, but sales success is paramount for this high-risk, high-reward bet.

📈

Unlock the full report

Create a free account to see the DVR score, risk flags, and AI analysis.

🔥 New Member Exclusive

Unlock everything for $47/yr

$79/yrSave 41%

✓ Catalysts, bull case, moat & red flags
✓ Unlimited stock analyses + alerts
✓ Full database, search & portfolio (50 stocks)

Get Premium — $47/yr

7-day money back · Cancel anytime

SCPH Financial Health Metrics

Market Cap

$304.36M

🔔

Never miss a move on SCPH

Create a free account to set price alerts and get notified on Telegram when SCPH hits your targets.

📊 Explore More Stock Analysis

Get comprehensive Deep Value Reports for thousands of stocks. Research risk, financial health, and investment potential.

Analyze Any Stock →View Top 100 Deep Value Stocks →

FAQ

What is the DVR Score for scPharmaceuticals Inc. (SCPH)?

As of October 7, 2025, scPharmaceuticals Inc. has a DVR Score of 8.4 out of 10, placing it in the "Hidden Gem" category. This score is generated by our AI-powered deep value analysis framework that evaluates growth potential, financial health, competitive moat, and risk factors.

What is the market capitalization of scPharmaceuticals Inc.?

scPharmaceuticals Inc.'s market capitalization is approximately $304.4M. The company operates in the Healthcare sector within the Biotechnology industry.

What ticker symbol does scPharmaceuticals Inc. use?

SCPH is the ticker symbol for scPharmaceuticals Inc.. The company trades on the NMS.

How often is the SCPH DVR analysis updated?

Our AI-powered analysis of scPharmaceuticals Inc. is refreshed regularly to incorporate the latest financial data, market conditions, and news. The most recent update was on October 7, 2025.

Important Disclaimer – Not Financial Advice

Deep Value Reports is an independent research platform for educational and informational purposes only. We are not financial advisors, investment advisors, or licensed professionals. The analysis, scores, and information provided should not be construed as personalized investment advice, a recommendation to buy or sell any security, or an offer to provide investment advisory services.

All investments involve risk, including the potential loss of principal. Past performance does not guarantee future results. Always conduct your own research and consult with a qualified financial advisor.